<?xml version="1.0" encoding="UTF-8"?>
<p>The method of Noshad et al. (
 <xref rid="fsn32186-bib-0029" ref-type="ref">2018</xref>) was used to evaluate the antibacterial effect of the CEO against some pathogenic gram‐positive bacteria (
 <italic>Staphylococcus aureus</italic>, 
 <italic>Listeria innocua</italic>, and 
 <italic>Bacillus cereus</italic>) and gram‐negative bacteria (
 <italic>Escherichia coli</italic>, 
 <italic>Pseudomonas aeruginosa</italic>, and 
 <italic>Salmonella typhi</italic>), through disk diffusion agar (DDA), well diffusion agar (WDA), and minimum inhibitory/bactericidal concentration (MIC/MBC) methods.
</p>
